No results for ‘’
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO BSE: 500660
₹2346.80
(1.78%)
Mon, 25 May 2026, 10:02 pm
Market Cap404.69B
PE Ratio38.38
Dividend1.76
Health Technology
Pharmaceuticals: Major
24.5KGlaxosmithkline Pharmaceuticals Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11373 | 1424.4 | 03 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11373 | 1424.4 | 03 Oct 2022 |
Showing 1–10 of 20
Rows per page: